GrantPostedDiscretionary

DoW Breast Cancer, Clinical Research Extension Award

Dept. of the Army -- USAMRAA
HT942526BCRPCREA
Application Deadline
Jul 8, 2026
Closed
Days Remaining
0
Deadline passed
Award Ceiling
Total Program Funding
$15,400,000

Grant Opportunity Analysis

The Department of the Army’s USAMRAA is funding the FY26 Breast Cancer Research Program Clinical Research Extension Award to support research that extends existing breast cancer clinical studies. The award is intended to strengthen the clinical value of prior patient participation by continuing data collection, follow-up, and analysis to address gaps from early trial termination, limited follow-up, or incomplete data collection. Applications must address at least one FY26 BCRP overarching challenge or justify an exception, and the research team must include two or more breast cancer consumer advocates; the mechanism allows either a single PI or a partnering PI structure. The program expects about $15.4 million to support roughly two awards, with a pre-application due June 24, 2026 and a full application due July 8, 2026, and questions may be directed to the eBRAP Help Desk at help@eBRAP.org or 301-682-5507.

Eligible Applicants

Unrestricted

Grant Documents

1 File

Related Grant Opportunities

Project Timeline

postedOriginal Opportunity PostedMay 4, 2026
deadlineApplication DeadlineJul 8, 2026
expiryArchive DateAug 7, 2026

Funding Details

Est. Total Program Funding
$15,400,000
Expected Awards
2
No cost sharing required

Agency & Classification

Agency
Dept. of the Army -- USAMRAA(DOD-AMRAA)
Funding Category
Science and Technology and other Research and Development
Funding Instrument
Grant

Grantor Contact

CFDA Numbers

12.420

Official Sources